Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol + ketamine versus propofol sedation for TOE-guided cardioversion in atrial fibrillation
ACTRN12609000750280Phase 4Terminated
- Sponsor
- Fremantle Hospital
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol and ketamine in Atrial fibrillation (AFib) (2 arms), sponsored by Fremantle Hospital. Primary endpoint: Tissue tracking displacement. Started Oct 2009; status: terminated.
02
Drugs
propofolketamine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on ACTRN12609000750280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000750280.